In the Range: Real Talk on Diabetes Monitoring Best Practices
The diabetes monitoring landscape continues to rapidly evolve, producing a CALL-TO-ACTION for HCPs to stay up-to-date and implement advances in practice.
- CGM benefits are numerous, resulting in leading diabetes organizations expanding recommendations for use to all people with diabetes.
- Despite these recommendations, use of CGM in practice remains low, even in people on insulin.
- Ketone monitoring is a staple in diabetes management for the prevention of DKA, but current methods are suboptimal.
- Gaps in care are paving the way for advances in continuous ketone monitoring (CKM), demonstrated by the development of an international consensus document on CKM for people with diabetes.
Resource Center
Discover a curated collection of foundational, practical, and real-world educational resources at your fingertips. Click on a link to get started.
Slide Decks
4 items
Episode 1: DKA in Focus: What the New Consensus Means for Practice
Slide DeckEpisode 2: Why Don't More Patients have CGM?
Slide DeckEpisode 3: DKA in the Real World: Evidence and Cases that Matter
Slide DeckEpisode 4: CGM in the Real T2D World
Slide DeckSteering Committee
Meet the expert faculty behind In the Range: Real Talk on Diabetes Monitoring Best Practices.
Ketan Dhatariya, MBBS, MSc, MD, MS, FRCP, PhD
Consultant in Diabetes and Endocrinology
Norfolk and Norwich University Hospitals
Honorary Professor of Medicine
University of East Anglia, UK
Jennifer Sherr, MD, PhD
Professor of Pediatrics, Pediatric Endocrinology
Medical Director, Pediatric Diabetes
Yale University School of Medicine
New Haven, CT
Davida F. Kruger, CNP
Certified Nurse Practitioner
Henry Ford Health
Division of Endocrinology, Diabetes, Bone and Mineral Disease
Detroit, MI
Carol Wysham, MD
Associate Clinical Professor of Medicine
University of Washington, Seattle
Research Professor of Pharmacotherapy
Washington State University, Spokane, Washington
Samuel Seidu, MD, FRCP(Edin), FRCGP
Professor of Primary Care Diabetes and Cardiometabolic Medicine
University of Leicester
Leicester, England
Jennifer Goldman, PharmD, CDCES, BC-ADM-FCCP
Professor of Pharmacy Practice
Clinical Pharmacist, Well Life Pharmacy Practice
Massachusetts College of Pharmacy and Health Sciences
Boston, MA
Francisco Javier Ampudia-Blasco, MD, PhD
Endocrinologist; Section Chief – Endocrinology & Diabetes
Department of Endocrinology & Nutrition, Clinic University Hospital Valencia
Professor, Department of Medicine, University of Valencia
Valencia, Spain
This curriculum is jointly provided by Cornerstone Medical Education and the American Academy of CME.
Supported by an independent educational grant from Abbott Diabetes Care.
